PhaseBio Pharmaceuticals, Inc.
PHAS · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$131 | -$98,565 | -$39,247 | -$23,846 |
| Dep. & Amort. | $1,793 | $508 | $174 | $105 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,268 | $2,237 | $1,421 | $332 |
| Change in WC | $29,368 | -$4,262 | -$2,442 | $2,027 |
| Other Non-Cash | -$80,714 | $40,125 | $500 | $4,329 |
| Operating Cash Flow | -$47,416 | -$59,957 | -$39,594 | -$17,053 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,679 | -$1,412 | -$960 | -$119 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,679 | -$1,412 | -$960 | -$119 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $60,354 | $2,942 | $46,277 | $42,974 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $63,773 | $15,466 | $53,528 | $64,797 |
| Financing Cash Flow | $63,773 | $15,466 | $53,528 | $64,797 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $13,678 | -$45,903 | $12,974 | $47,625 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,122 | $74,025 | $61,051 | $13,426 |
| End Cash | $41,800 | $28,122 | $74,025 | $61,051 |
| Free Cash Flow | -$50,095 | -$61,369 | -$40,554 | -$17,172 |